Previous Meetings

GBCC 2022

Global Breast Cancer Conference 2022

09:00-10:15
Symposium 1
Evolving Treatment Strategies for ER+/HER2- Breast Cancer
Venue: RM 1(Vista 1+2)
  • Upfront Surgery vs. Neoadjuvant Systemic Therapy to Optimize Locoregional Management in ER+/HER2- Breast Cancer
    Wonshik Han (Seoul National Univ. Hospital, Korea)
  • Beyond Endocrine Therapy for High-risk Early ER+/HER2- Breast Cancer After Neoadjuvant Chemotherapy
    Masakazu Toi (Kyoto Univ. Hospital, Japan)
  • Various Targeted Therapies for Advanced ER+/HER- Breast Cancer: To Whom Should We Give Which?
    Komal Jhaveri (Memorial Sloan Kettering Cancer Center, U.S.A.)
Panel Discussion 1
Challenges of Artificial Intelligence(AI) in Fields of Breast Cancer Care
Venue: RM 2(Vista 3)
  • AI Meets Surgeon, Where Are We and How to Use?
    Beomseok Ko (ASAN Medical Center, Korea)
  • Application of AI-based Breast Imaging and Diagnosis
    Heang-Ping Chan (Univ. of Michigan, U.S.A.)
  • The Use of AI for Personalized Radiation Therapy
    Bum-Sup Jang (Seoul National Univ. Hospital, Korea)
Education Session 1
Breast Cancer Screening in the Era of Precision Medicine
Venue: RM 3(Walker Hall 1)
  • Implementing Risk Assessment in the Routine Practice
    Su Hyun Lee (Seoul National Univ. Hospital, Korea)
  • Novel Paradigms for Tailored Screening including Contrast Mammography and MRI
    Christopher E. Comstock (Memorial Sloan Kettering Cancer Center, U.S.A.)
  • AI in Screening and Diagnostic Breast Imaging
    Jung Hyun Yoon (Severance Hospital, Korea)
Oral Presentation 1
Venue: RM 4(Walker Hall 2)
GBCC-JBCS Joint Session 1
Joint Clinical Trials for De-escalation and Escalation of Locoregional Treatment of Breast Cancer
Venue: RM 5(Art Hall)
  • Omission of Surgery for Pathologic Complete Response Diagnosed with MRI and BIopsy in Breast Cancer After Neoadjuvant Chemotherapy: OPTIMIST Trial
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • Trials of Surgery in Japan
    Hideo Shigematsu (National Hospital Organization Kure Medical Center and Chugoku Cancer Center , Japan)
  • Impact of Post-mastectomy Radiotherapy in Breast Cancer Patients with Excellent Response After Neoadjuvant Chemotherapy: A Phase 3, Multicenter, Randomized, Non-inferiority Study
    Soong June Bae (Gangnam Severance Hospital, Korea)
  • Trials of Radiation Therapy in Japan
    Chikako Yamauchi (Shiga General Hospital, Japan)
10:30-11:45
Symposium 2
Novel Breakthrough in the Treatment of HER2+ Breast Cancer
Venue: RM 1(Vista 1+2)
  • Antibody-Drug Conjugates and Engineered Antibodies
    Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
  • HER2 Targeted TKI: Overview and Overcoming Resistance
    Shaheenah Dawood (Mediclinic City Hospital, U.A.E.)
  • A New Promise: HER2 Vaccines and Immunotherapy
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
Panel Discussion 2
Nationwide Big Data for Clinical Research in Breast Cancer
Venue: RM 2(Vista 3)
  • Leveraging Large Data Bases (SEER/NCDB) to Create Scientific Rigor for Clinical Trials in Breast Cancer
    Mehra Golshan (Yale School of Medicine, U.S.A.)
  • Breast Cancer Research Using National Health Insurance Database in Korea
    Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)
  • Clinicopathological Characteristics of Male Breast Cancer in Japan from the National Clinical Database
    Akihiko Shimomura (National Center for Global Health and Medicine, Japan)
Education Session 2
Less Toxic Breast Radiotherapy
Venue: RM 3(Walker Hall 1)
  • Partial Breast Irradiation: A Beginner's Guide
    Ji Hyun Chang (Seoul National Univ. Hospital, Korea)
  • Heart Sparing RT: A Practical Consideration
    Shu-Lian Wang (Chinese Academy of Medical Sciences, China)
  • Advanced Techniques in Breast RT: from IMRT to Particle Therapy
    Rachel Jimenez (Massachusetts General Hospital, U.S.A.)
Oral Presentation 2
Venue: RM 4(Walker Hall 2)
GBCC-JBCS Joint Session 2
Joint Clinical Trials for De-escalation and Escalation of Systemic Treatment of Breast Cancer
Venue: RM 5(Art Hall)
  • Randomized, Phase II Trial to Evaluate the Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy Compared to Capecitabine Monotherapy for Triple Receptor-Negative Breast Cancer with Residual Invasive Cancer after Neoadjuvant Chemotherapy (MIRINAE trial, KCSG-BR18-21)
    In Hae Park (Korea Univ. Guro Hospital, Korea)
  • Trials of ER(+) Cancer in Japan
    Toshimi Takano (The Cancer Institute Hospital of JFCR, Japan)
  • Ovarian Function Suppression in Premenopausal Women with Node Positive Disease and Low Genomic Risk: OPAL Trial
    Tae-Kyung Robyn Yoo (ASAN Medical Center, Korea)
  • Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy in Older Patients: RESPECT Trial
    Masataka Sawaki (Aichi Cancer Center Hospital, Japan)
12:00-12:45
Plenary Lecture 1
Venue: RM 1(Vista 1+2)
  • Targeting Homologous Recombination Deficient Breast Cancer: Moving from Advanced to Early Disease
    Andrew Tutt (Institute of Cancer Research, King’s College London, UK)
13:00-13:45
Satellite Symposium 1
Pfizer Korea
Venue: RM 1(Vista 1+2)
  • Maximizing Clinical Outcome in HR+HER2- Metastatic Breast Cancer Patients: Palbociclib & CDK4/6 Inhibitors in Real-world Practice
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
14:00-14:45
Plenary Lecture 2
Venue: RM 1(Vista 1+2)
  • Harnessing the Value Afforded by Whole Genome Sequencing of Breast Cancers
    Serena Nik-Zainal (Univ. of Cambridge, UK)
15:00-16:15
Panel Discussion 3
Fertility Preservation for Younger Breast Cancer Patients
Venue: RM 2(Vista 3)
  • How I Perform Fertility Preservation in Breast Cancer Patients
    Matteo Lambertini (IRCCS Policlinico San Martino Hospital - Univ. of Genova, Italy)
  • Onco-fertility Modules and Conseling in Young Women with Breast Cancer: Asian Experience
    Heejeong Kim (ASAN Medical Center, Korea)
  • Shared Decision Making for Fertility Preservation
    Ling-Ming Tseng (Taipei Veterans General Hospital, Taiwan)
Education Session 3
Optimal Therapy for Women with Early Breast Cancer
Venue: RM 3(Walker Hall 1)
  • Neoadjuvant and Adjuvant Treatment for Triple Negative Breast Cancer
    Bora Lim (Baylor College of Medicine, U.S.A.)
  • Neoadjuvant and Adjuvant Treatment for HER2-positive Breast Cancer
    Joohyuk Sohn (Yonsei Cancer Center, Korea)
  • Use of Multigene Assay in HR+HER2- Breast Cancer
    Tom Wei-Wu Chen (National Taiwan Univ. Hospital, Taiwan)
Endoscopic and Robotic Breast Surgery Session
Recent Updates for Endoscopic and Robotic Breast Surgery
Venue: RM 4(Walker Hall 2)
  • Benefits and Drawbacks: Multi-port Robotic Mastectomy
    Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
  • Benefits and Drawbacks: Single-port Robotic Mastectomy
    Hyung Seok Park (Severance Hospital, Korea)
  • Recent Updates for Endoscopic Mastectomy with Axillary Surgery
    Chi Wei Mok (Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)
  • Endoscopic/Robotic-assisted Harvest of Latissimus Dorsi Flap for Partial Breast Reconstruction
    Jung Dug Yang (Kyungpook National Univ. Chilgok Hospital, Korea)
GBCC Sino-Korean Joint Session
Taking Actions Against Increasing Asian Breast Cancer Burden
Venue: RM 5(Art Hall)
  • Current Status and Future Strategy for Sporadic and Hereditary Breast Cancer in Asia
    Sang Yull Kang (Jeonbuk National Univ. Hospital, Korea)
  • Optimal Management for Chinese Women with Hereditary Breast Cancer
    Yuntao Xie (Peking Univ. Cancer Hospital, China)
16:30-17:45
Panel Discussion 4
Geriatric Oncology for Elderly Breast Cancer Patients
Venue: RM 2(Vista 3)
  • Is It safe to Omit Radiotherapy After Breast Conserving Surgery in Elderly Patients?
    Icro Meattini (Univ. of Florence, Italy)
  • Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Multiple Comorbidities
    Akimitsu Yamada (Yokohama City Univ. Hospital, Japan)
  • Prediction of Severe Toxicity in Older Adults Receiving Chemotherapy for Early-stage Breast Cancer
    In Sook Woo (The Catholic Univ. of Korea, Yeouido St. Mary's Hospital, Korea)
Education Session 4
Consideration of Particular Type of Breast Neoplasm
Venue: RM 3(Walker Hall 1)
  • Update on Management of Phyllodes Tumors of the Breast
    Jeong Eun Kim (ASAN Medical Center, Korea)
  • Overview of Metaplastic Breast Cancer
    Sunil Lakhani (Univ. of QLD and Pathology QLD, Australia)
  • Recent Updates in Pathology of LCIS, ALH, and ADH
    Aeree Kim (Korea Univ. Guro Hospital, Korea)
OPBS Session
Future Perspectives in Oncoplastic Breast Surgery: From Personal to Professional
Venue: RM 4(Walker Hall 2)
  • Training the Oncoplastic Breast Surgeon: An International Perspective
    Patricia Lynn Clark (Ironwood Cancer and Research Centers, U.S.A.)
  • Evidence Reviews of Oncoplastic Breast Surgery
    Visnu Lohsiriwat (Siriraj Hospital, Mahidol Univ., Thailand)
  • Overcoming Hurdles in Oncoplastic Breast Surgery
    Jeeyeon Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Plastic Surgeon's Perspective for Better Reconstruction Outcomes
    Ung Sik Jin (Seoul National Univ. Hospital, Korea)
GBCC-TBCS Joint Session
Continuous Development and Networking Between Young Doctors in Two Countries
Venue: RM 5(Art Hall)
  • Education and Developmental Program for Young Doctors in Korea
    Soo Kyung Ahn (Hallym Univ. Kangnam Sacred Heart Hospital, Korea)
  • Education and Developmental Program for Young Doctors in Taiwan
    Yen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
Back to Previous Meetings